These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39069389)

  • 1. Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines Update.
    Skolarikos A; Somani B; Neisius A; Jung H; Petřík A; Tailly T; Davis N; Tzelves L; Geraghty R; Lombardo R; Bezuidenhout C; Gambaro G
    Eur Urol; 2024 Oct; 86(4):343-363. PubMed ID: 39069389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
    Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
    Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of urinary stones: state of the art and future perspectives by experts in stone disease.
    Papatsoris A; Alba AB; Galán Llopis JA; Musafer MA; Alameedee M; Ather H; Caballero-Romeu JP; Costa-Bauzá A; Dellis A; El Howairis M; Gambaro G; Geavlete B; Halinski A; Hess B; Jaffry S; Kok D; Kouicem H; Llanes L; Lopez Martinez JM; Popov E; Rodgers A; Soria F; Stamatelou K; Trinchieri A; Tuerk C
    Arch Ital Urol Androl; 2024 Jun; 96(2):12703. PubMed ID: 38934520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
    Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
    J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Urology; 2014 Oct; 84(4):766-71. PubMed ID: 25106943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urolithiasis: Update on Metabolic Evaluation of Stone Formers.
    Park S; Pearle MS
    ScientificWorldJournal; 2005; 5():902-914. PubMed ID: 29861685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four-hour urine osmolality as a representative index of adequate hydration and a predictor of recurrence in patients with urolithiasis.
    Kang HW; Seo SP; Ha YS; Kim WT; Kim YJ; Yun SJ; Kim WJ; Lee SC
    Int Urol Nephrol; 2019 Jul; 51(7):1129-1135. PubMed ID: 31089946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.
    Zeng G; Zhu W; Robertson WG; Penniston KL; Smith D; Pozdzik A; Tefik T; Prezioso D; Pearle MS; Chew BH; Veser J; Fiori C; Deng Y; Straub M; Türk C; Semins MJ; Wang K; Marangella M; Jia Z; Zhang L; Ye Z; Tiselius HG; Sarica K
    Urolithiasis; 2022 Dec; 51(1):4. PubMed ID: 36454329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
    Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
    Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?
    Tiselius HG
    Urolithiasis; 2016 Feb; 44(1):91-100. PubMed ID: 26614110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Association of Urology and European Society for Paediatric Urology Guidelines on Paediatric Urinary Stone Disease.
    Tekgül S; Stein R; Bogaert G; Nijman RJM; Quaedackers J; 't Hoen L; Silay MS; Radmayr C; Doğan HS
    Eur Urol Focus; 2022 May; 8(3):833-839. PubMed ID: 34052169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of recurrence of urolithiasis].
    Siener R; Stein J; Ritter M
    Urologie; 2024 Apr; 63(4):387-395. PubMed ID: 38466398
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.